Akorn (AKRX) ROE - Return on Equity
Current and historical Return on Equity (ROE) values for Akorn (AKRX) over the last 10 years.
|Medical||Medical - Generic Drugs||$3.995B||$1.117B|
|Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products. Customers include physicians, optometrists, wholesalers, group purchasing organizations and otherpharmaceutical companies. They also provide contract manufacturingservices.|